Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial

Author(s):: Schneider, T.C.; Wit, D. de; Links, T.P.; Erp, N.P. van; Hoeven, J.J.M. van der (0000-0003-1117-1959); Gelderblom, H.; Wezel, T. van; Eijk, R. van; Morreau, H.; Guchelaar, H.J. (0000-0002-7085-1383); Kapiteijn, E.

Published: 2015
Publication type: Article / Letter to editor

Date issued: 2015-12-31
Language: English
Is part of: International Journal of Endocrinology
hdl: 1887/107907
doi: 10.1155/2015/348124